GNH USA

Europe — EMA

Levosulpirida Stada (Levosulpiride)

GNH USA supplies Levosulpirida Stada (Levosulpiride), a benzamide antipsychotic for schizophrenia, depressive disorders, dyspepsia and GERD. Request a quote.

Levosulpiride

Request sourcing

1
Pack/s

What is Levosulpiride?

Levosulpiride, the active ingredient in Levosulpirida Stada, is a benzamide derivative presented as an oral formulation for oral use. It treats schizophrenia, depressive disorders, functional dyspepsia and gastroesophageal reflux disease in adult patients.

GNH USA supplies Levosulpirida Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide.

What is Levosulpiride used for?

Levosulpiride is used in psychiatric and gastrointestinal disorders that involve dopamine dysregulation.

- Schizophrenia: alleviates positive and negative symptoms in adult patients. - Depressive disorders: augments antidepressant response and improves mood. - Functional dyspepsia: enhances gastric motility and reduces dyspeptic discomfort. - Gastroesophageal reflux disease: increases lower esophageal sphincter tone and decreases reflux episodes.

What are the side effects of Levosulpiride?

Levosulpiride may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Nausea - Headache - Dizziness - Dry mouth

Serious or Rare Side Effects: - Extrapyramidal symptoms such as akathisia or dystonia - Neuroleptic malignant syndrome - Severe allergic reactions, including anaphylaxis

What precautions apply to Levosulpiride?

Use of levosulpiride requires careful consideration of several safety aspects.

- Pregnancy: safety not established; avoid unless clearly needed. - Breastfeeding: unknown excretion; consider risk versus benefit. - Renal impairment: dose adjustment may be required. - Hepatic impairment: use with caution and monitor liver function. - Elderly patients: increased sensitivity to central effects; start at low dose. - Store at room temperature: keep in original packaging, protect from moisture and light.

What does Levosulpiride interact with?

Levosulpiride can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Strong D2 antagonists (e.g., haloperidol): heightened risk of extrapyramidal effects. - Monoamine oxidase inhibitors: potential for hypertensive crisis. - QT‑prolonging agents (e.g., quinidine): additive cardiac risk.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may increase levosulpiride plasma levels. - Central nervous system depressants (e.g., benzodiazepines): enhanced sedation.

Frequently asked questions

What conditions is Levosulpirida Stada used to treat?+
Levosulpirida Stada is prescribed for adult patients with schizophrenia, depressive disorders, functional dyspepsia and gastroesophageal reflux disease. In psychiatry it helps control psychotic symptoms, while in gastro‑intestinal practice it improves gastric motility and reduces reflux episodes.
How does levosulpiride work in the body?+
Levosulpiride acts as a selective dopamine D2‑receptor antagonist. By blocking D2 receptors in the brain it reduces dopaminergic activity that contributes to psychosis. Peripherally, the same antagonism stimulates gastrointestinal smooth‑muscle activity, providing a prokinetic effect that aids digestion and lower‑esophageal sphincter tone.
What determines the dose of Levosulpirida Stada?+
The exact dose is set by the prescribing clinician based on the specific indication, severity of disease, patient age, renal and hepatic function, and any concomitant medications. No universal dosing regimen is provided; the prescriber tailors therapy to each individual’s clinical situation.
Is Levosulpirida Stada safe during pregnancy or breastfeeding?+
Safety data for levosulpiride in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare professional.
How do I order Levosulpirida Stada from GNH USA?+
To request Levosulpirida Stada, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does levosulpiride compare with other antipsychotic drugs?+
Levosulpiride is an atypical antipsychotic that selectively blocks dopamine D2 receptors while having minimal affinity for serotonin receptors. Compared with many typical antipsychotics, it tends to produce fewer metabolic side effects but may still cause extrapyramidal symptoms. Its additional prokinetic activity makes it useful for certain gastrointestinal conditions, a feature not shared by most other antipsychotics.
What are the recommended storage conditions for Levosulpirida Stada?+
Levosulpirida Stada should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and store it out of reach of children. Do not refrigerate or freeze the tablets.
How is Levosulpirida Stada administered?+
Levosulpirida Stada is taken orally. The tablets should be swallowed whole with a glass of water and can be taken with or without food, unless the prescriber advises otherwise. Patients should follow the dosing schedule provided by their healthcare professional.
What are the most serious risks associated with Levosulpirida Stada?+
Serious adverse reactions include extrapyramidal symptoms such as akathisia or dystonia, neuroleptic malignant syndrome—a rare but life‑threatening condition—and severe allergic responses like anaphylaxis. Prompt medical attention is required if any of these events occur.
Who should not use Levosulpirida Stada?+
Levosulpirida Stada is contraindicated in patients with known hypersensitivity to levosulpiride or any excipients, those taking monoamine oxidase inhibitors, and individuals with uncontrolled cardiac arrhythmias or severe QT prolongation. Caution is also advised for patients with significant renal or hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Levosulpiride
Route
Oral Use
Manufacturer
Laboratorio Stada, S.L.
Origin
EU

Related products

Argopro

Argopro

Levosulpiride

Dompé Farmaceutici S.P.A.
EU
Levair

Levair

Levosulpiride

Epifarma S.R.L.
EU
Levide

Levide

Levosulpiride

Medochemie Ltd.
EU
Levide

Levide

Levosulpiride

Medochemie Ltd.
EU